Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder (ADHD)
Primary Purpose
Inattentive, Hyperactivity, Impulsivity
Status
Completed
Phase
Early Phase 1
Locations
Egypt
Study Type
Interventional
Intervention
Probiotic Formula lacteal forte
Sponsored by
About this trial
This is an interventional treatment trial for Inattentive focused on measuring Hyperactivity, Inattention, Probiotics
Eligibility Criteria
Inclusion Criteria:
- Age from 6 to 16 years old.
- Children fulfilled DSM(V) Criteria for ADHD syndrome.
Exclusion Criteria:
- Intelligence quotient (IQ) less than 80% .
- Presence of other medical conditions as chronic medical or neuropsychiatric disorders e.g diabetes mellitus, epilepsy…..etc. hearing or visual impairment, or medications side effects.
- currently taking probiotics or antibiotics
Sites / Locations
- Reham Ibrahim
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Patient with attention deficit hyperactive disorser
ADHD not receiving probiotics
Arm Description
patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to standard treatment
ADHD patient (40) on standard treatment
Outcomes
Primary Outcome Measures
Conner's Parent Rating Scales-Revised (CRS-R):for follow up
This tool is used in order to assess the profile and severity of symptoms, response to treatment and follow up studies. Items are scored on 14 subscales of symptoms including opposition, cognitive problems, inattention, and hyperactivity.It is usually considered normal when T-scores are less than 60, while scores above 60 are signs of academic, behavioral, or social issues. There are several different classes as well
Child behavior checklist
Parent form to asses the associated internalizing and externalizing behaviour
Secondary Outcome Measures
Conners Continuous Performance Test (CPT)
To asses sustained attention and impulsivity
Wisconsin (Berg) Card Sort Test (WCST)
To evaluate executive function
Full Information
NCT ID
NCT04167995
First Posted
November 12, 2019
Last Updated
December 23, 2022
Sponsor
Ain Shams University
1. Study Identification
Unique Protocol Identification Number
NCT04167995
Brief Title
Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder
Acronym
ADHD
Official Title
Assessment of Probiotic Strain Lactobacillus Acidophilus LB Supplementation as Adjunctive Management of Attention-deficit Hyperactivity Disorder in Children and Adolescents: a Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
June 9, 2020 (Actual)
Primary Completion Date
November 9, 2020 (Actual)
Study Completion Date
October 30, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
ADHD is a neurodevelopmental disorder characterized by persistent symptoms of inattention and/or hyperactivity and impulsivity that are present before age 18. These symptoms must be evident across ADHD treatment is currently based on a multimodal approach with the combination of psychotherapy and pharmacotherapy, but no reliable markers of treatment response have been identified yet and 20-35% of subjects in clinical trials may have an inadequate response to the treatment The gut microbiome refers to the microbial ecosystem found in the gastrointestinal system of the human species Probiotics are a type of beneficial bacteria that improve health and facilitate intestinal microbial balance Increasing evidence suggests that the gut microbiota plays a key role in the gut-brain communication axis by influencing metabolism, inflammation, the hypothalamic-pituitary-adrenal axis, and neurotransmission multiple domains and cause Impairment in functioning in order to meet the diagnostic criteria for ADHD
Detailed Description
All patients will be randomly distributed into two equal groups using a random number generator from computer-based randomization software. the probiotic group (n=40) received probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony-forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to a weight-dependent dose of standard treatment (Atomoxetine), and the 40 patients in the control group will not receive the probiotic and on a weight-dependent dose of atomoxetine.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inattentive, Hyperactivity, Impulsivity
Keywords
Hyperactivity, Inattention, Probiotics
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Masking Description
Using a computer-based randomization program. The allocation was concealed in sealed envelopes. Only the researchers collecting and analyzing the data were blinded to the study groups (assessor-blinded).
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patient with attention deficit hyperactive disorser
Arm Type
Active Comparator
Arm Description
patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to standard treatment
Arm Title
ADHD not receiving probiotics
Arm Type
No Intervention
Arm Description
ADHD patient (40) on standard treatment
Intervention Type
Drug
Intervention Name(s)
Probiotic Formula lacteal forte
Other Intervention Name(s)
Lacteal forte
Intervention Description
Active Comparator: Patient with attention deficit hyperactive disorder patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks .
Primary Outcome Measure Information:
Title
Conner's Parent Rating Scales-Revised (CRS-R):for follow up
Description
This tool is used in order to assess the profile and severity of symptoms, response to treatment and follow up studies. Items are scored on 14 subscales of symptoms including opposition, cognitive problems, inattention, and hyperactivity.It is usually considered normal when T-scores are less than 60, while scores above 60 are signs of academic, behavioral, or social issues. There are several different classes as well
Time Frame
3 months
Title
Child behavior checklist
Description
Parent form to asses the associated internalizing and externalizing behaviour
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Conners Continuous Performance Test (CPT)
Description
To asses sustained attention and impulsivity
Time Frame
3 months
Title
Wisconsin (Berg) Card Sort Test (WCST)
Description
To evaluate executive function
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age from 6 to 16 years old.
Children fulfilled DSM(V) Criteria for ADHD syndrome.
Exclusion Criteria:
Intelligence quotient (IQ) less than 80% .
Presence of other medical conditions as chronic medical or neuropsychiatric disorders e.g diabetes mellitus, epilepsy…..etc. hearing or visual impairment, or medications side effects.
currently taking probiotics or antibiotics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reham Ibrahim
Organizational Affiliation
Ain Shams University
Official's Role
Study Director
Facility Information:
Facility Name
Reham Ibrahim
City
Cairo
ZIP/Postal Code
11757
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder
We'll reach out to this number within 24 hrs